CARLSBAD, CALIFORNIA–(Marketwired – April 14, 2016) – Aurora Spine Corporation (TSX VENTURE:ASG) announced today the allowance by the United States Patent and Trademark Office of United States Patent Application Serial No. 13/865,155 entitled “Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation System”. This patent covers Aurora’s family of ZIP® ISPs, including its ZIP Ultra®, ZIP 51™, ZIP LP™ and Dyna-ZIP™ among others.
“Aurora is changing spine surgery, and we are thrilled that our patent has been allowed by the United States Patent and Trademark Office (USPTO). This patent further validates the unique and pioneering nature of our ZIP® Interspinous implants,” said Trent Northcutt, President and CEO of Aurora Spine, “and it maintains our ability to continue introducing advanced spinal technologies.”
“The minimally invasive ZIP screw-less portfolio provides spine surgeons with our now ‘Patented’ ONE-STEP™ locking mechanism that eliminates the use of a set screw. The success of our Screwless Procedure™ is a testament to our dedicated focus on disruptive technology and our commitment to – Simplifying the Complex.”
This is Aurora’s first allowed U.S. patent. Aurora has several other U.S. and international patent applications pending directed to the ZIP system and its other spinal implant technologies.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to – Simplifying the Complex.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
Aurora Spine Corporation
President and Chief Executive Officer
Aurora Spine Corporation
Chief Financial Officer